Trials / Conditions / Breast Atypical Hyperplasia
Breast Atypical Hyperplasia
3 registered clinical trials studyying Breast Atypical Hyperplasia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction NCT06195306 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk f NCT05941520 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increa NCT04570956 | Mayo Clinic | Phase 2 |